Quantcast

Latest Psoriatic arthritis Stories

2014-08-27 12:30:09

Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology....

2014-08-21 08:28:17

INDIANAPOLIS, Aug. 21, 2014 /PRNewswire/ -- -- Ixekizumab met all primary and key secondary objectives across three pivotal studies of 3,866 patients, the largest Phase 3 moderate-to-severe plaque psoriasis program to date -- Ixekizumab was superior to etanercept on all measures of skin clearance in both active comparator studies -- Lilly plans regulatory submissions for ixekizumab in 1(st) half of 2015 Eli Lilly and Company's (NYSE: LLY)...

2014-08-20 08:27:57

Be Joint Smart to educate roughly 43,500 local residents with PsA about their disease PORTLAND, Ore., Aug. 20, 2014 /PRNewswire-USNewswire/ -- If you're one of the roughly 43,500 D.C. metro residents struggling with pain from psoriatic arthritis (PsA)--an inflammatory autoimmune disease that causes pain, swelling and stiffness of the joints and tendons--learn to control your condition with Be Joint Smart, a free psoriatic arthritis program presented by the National Psoriasis Foundation, at...

Rubbing Hands Together
2014-08-11 04:39:09

Rayshell Clapper for redOrbit.com - Your Universe Online Arthritis is a very painful inflammation of one or more of a person’s joints. It can simply be a dull, annoying ache, but arthritis may cause severe to debilitating pain. Many people suffer from different types of arthritis. To better understand arthritis, it is important to understand the common types that are regularly diagnosed. Medline Plus, a project supported by the National Institutes of Health, shows five major common types...

2014-07-31 16:27:53

NORWALK, Conn., July 31, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network, a leading online community for Rheumatologists, offers special coverage of the first joint meeting of two societies dedicated to related forms of arthritis, collectively known as spondyloarthritis. Spondyloarthritis is an important and treatable cause of chronic back pain. Psoriatic arthritis, which causes inflammation of the joints often including the lower back, arises in about 10% of patients...

2014-07-17 08:29:29

Nearly half a million dollars given to early-career physicians to study psoriatic disease PORTLAND, Ore., July 17, 2014 /PRNewswire-USNewswire/ -- Twelve residents and medical students each received a one-year, $50,000 National Psoriasis Foundation fellowship to study psoriasis. The fellowships aim to increase the number of scientists studying and treating psoriatic disease by encouraging promising doctors to dedicate their careers to the study of psoriasis and psoriatic arthritis as...

2014-07-16 08:28:17

PORTLAND, Ore., July 16, 2014 /PRNewswire-USNewswire/ -- Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis--an autoimmune disease that appears on the skin, affecting 7.5 million Americans--and psoriatic arthritis--an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis. Learn more about the NPF research...

2014-07-09 08:28:16

Psoriasis Foundation will drive efforts to cure psoriatic disease, help those affected PORTLAND, Ore., July 9, 2014 /PRNewswire-USNewswire/ -- National Psoriasis Foundation will double the number of researchers studying psoriasis and psoriatic arthritis while also cutting in half the number of people who say these chronic conditions are a problem in their daily lives as part of its new five-year strategic plan and mission to cure psoriatic disease and improve the lives of those affected....

2014-07-07 16:02:23

European League Against Rheumatism Low dosing of infliximab does not appear to alter treatment response or adherence Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit. Further data revealed that, in the case of the TNFα inhibitor...

2014-07-03 08:23:24

- Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union BRUSSELS and REDWOOD CITY, Calif., July 3, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical leader (Euronext: UCB), and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia(®) (certolizumab pegol) in dermatology. This collaboration aims...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related